The Journal of Allergy and Clinical Immunology
Volume 125, Issue 2 , Pages 449-460.e14 , February 2010

Involvement of sirtuin 1 in airway inflammation and hyperresponsiveness of allergic airway disease

  • So Ri Kim, MD, PhD

      Affiliations

    • Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, South Korea
    • Research Center for Pulmonary Disorders, Chonbuk National University Medical School, Jeonju, South Korea
    • These authors contributed equally to this work.
    • ,
  • Kyung Sun Lee, PhD

      Affiliations

    • Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, South Korea
    • Research Center for Pulmonary Disorders, Chonbuk National University Medical School, Jeonju, South Korea
    • These authors contributed equally to this work.
    • ,
  • Seoung Ju Park, MD, PhD

      Affiliations

    • Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, South Korea
    • Research Center for Pulmonary Disorders, Chonbuk National University Medical School, Jeonju, South Korea
    • These authors contributed equally to this work.
    • ,
  • Kyung Hoon Min, MD, PhD

      Affiliations

    • Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, South Korea
    • Research Center for Pulmonary Disorders, Chonbuk National University Medical School, Jeonju, South Korea
    • ,
  • Yeong Hun Choe, MD

      Affiliations

    • Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, South Korea
    • Research Center for Pulmonary Disorders, Chonbuk National University Medical School, Jeonju, South Korea
    • ,
  • Hee Moon, MD

      Affiliations

    • Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, South Korea
    • Research Center for Pulmonary Disorders, Chonbuk National University Medical School, Jeonju, South Korea
    • ,
  • Wan Hee Yoo, MD, PhD

      Affiliations

    • Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, South Korea
    • Research Center for Pulmonary Disorders, Chonbuk National University Medical School, Jeonju, South Korea
    • ,
  • Han-Jung Chae, PhD

      Affiliations

    • Department of Pharmacology, Chonbuk National University Medical School, Jeonju, South Korea
    • Research Center for Pulmonary Disorders, Chonbuk National University Medical School, Jeonju, South Korea
    • ,
  • Myung Kwan Han, PhD

      Affiliations

    • Department of Microbiology, Chonbuk National University Medical School, Jeonju, South Korea
    • ,
  • Yong Chul Lee, MD, PhD

      Affiliations

    • Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, South Korea
    • Research Center for Pulmonary Disorders, Chonbuk National University Medical School, Jeonju, South Korea
    • Corresponding Author InformationReprint requests: Yong Chul Lee, MD, PhD, Department of Internal Medicine, Chonbuk National University Medical School, San 2-20, Geumam-dong, Deokjin-gu, Jeonju, 561-180, South Korea.

Received 16 December 2008 ,Revised 10 August 2009 ,Accepted 12 August 2009.

References 

  1. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med. 2000;161:1720–1745
  2. Hamelmann E, Tadeda K, Oshiba A, Gelfand EW. Role of IgE in the development of allergic airway inflammation and airway hyperresponsiveness—a murine model. Allergy. 1999;54:297–305
  3. Zhang DH, Yang L, Cohn L, Parkyn L, Homer R, Ray P, et al. Inhibition of allergic inflammation in a murine model of asthma by expression of a dominant-negative mutant of GATA-3. Immunity. 1999;11:473–482
  4. Foster PS, Martinez-Moczygemba M, Huston DP, Corry DB. Interleukins-4, -5, and -13: emerging therapeutic targets in allergic disease. Pharmacol Ther. 2002;94:253–264
  5. Hassig CA, Schreiber SL. Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs. Curr Opin Chem Biol. 1997;1:300–308
  6. de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J. 2003;370:737–749
  7. Verdin E, Dequiedt F, Kasler HG. Class II histone deacetylases: versatile regulators. Trends Genet. 2003;19:286–293
  8. Hisahara S, Chiba S, Matsumoto H, Horio Y. Transcriptional regulation of neuronal genes and its effect on neural functions: NAD-dependent histone deacetylase SIRT1 (Sir2alpha). J Pharmacol Sci. 2005;98:200–204
  9. Yang SR, Wright J, Bauter M, Seweryniak K, Kode A, Rahman I. Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-κB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging. Am J Physiol Lung Cell Mol Physiol. 2007;292:L567–L576
  10. Yang T, Fu M, Pestell R, Sauve AA. SIRT1 and endocrine signaling. Trends Endocrinol Metab. 2006;17:186–191
  11. Lee YM, Kim SH, Kim HS, Son MJ, Nakajima H, Kwon HJ, et al. Inhibition of hypoxia-induced angiogenesis by FK228, a specific histone deacetylase inhibitor, via suppression of HIF-1alpha activity. Biochem Biophys Res Commun. 2003;300:241–246
  12. Rane S, He M, Sayed D, Vashistha H, Malhotra A, Sadoshima J, et al. Downregulation of MiR-199a derepresses hypoxia-inducible factor-1α and sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res. 2009;104:879–886
  13. Laemmle A, Vorburger S, Keogh A, Roh V, Candinas D, Stroka D. Targeting the histone deacetylase-sirt1 for anti-tumor therapy: inhibition of sirt1 down-regulates hif-1. J Hepatol. 2008;48(suppl):S133–S134
  14. Semenza GL. Hypoxia-inducible factor 1: control of oxygen homeostasis in health and disease. Pediatr Res. 2001;49:614–617
  15. Feldser D, Agani F, Iyer NV, Pak B, Ferreira G, Semenza GL. Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Cancer Res. 1999;59:3915–3918
  16. Jung YJ, Isaacs JS, Lee S, Trepel J, Neckers L. IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J. 2003;17:2115–2117
  17. Lee KS, Park SJ, Kim SR, Min KH, Jin SM, Puri KD, et al. Phosphoinositide 3-kinase-delta inhibitor reduces vascular permeability in a murine model of asthma. J Allergy Clin Immunol. 2006;118:403–409
  18. Lee KS, Kim SR, Park SJ, Park HS, Min KH, Jin SM, et al. Peroxisome proliferator activated receptor-gamma modulates reactive oxygen species generation and activation of nuclear factor-kappaB and hypoxia-inducible factor 1alpha in allergic airway disease of mice. J Allergy Clin Immunol. 2006;118:120–127
  19. Lee YC, Lee HK. Vascular endothelial growth factor in patients with acute asthma. J Allergy Clin Immunol. 2001;107:1106
  20. Lee YC, Kwak YG, Song CH. Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. J Immunol. 2002;168:3595–3600
  21. Lee KS, Kim SR, Park SJ, Lee HK, Park HS, Min KH, et al. Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) reduces vascular endothelial growth factor expression in allergen-induced airway inflammation. Mol Pharmacol. 2006;69:1829–1839
  22. Lee KS, Kim SR, Park SJ, Min KH, Lee KY, Choe YH, et al. Mast cells can mediate vascular permeability through regulation of the PI3K-HIF-1alpha-VEGF axis. Am J Respir Crit Care Med. 2008;178:787–797
  23. Lee KS, Kim SR, Park HS, Park SJ, Min KH, Lee KY, et al. A novel thiol compound, N-acetylcysteine amide, attenuates allergic airway disease by regulating activation of NF-kappaB and hypoxia-inducible factor-1alpha. Exp Mol Med. 2007;39:756–768
  24. Lee KS, Park SJ, Kim SR, Min KH, Lee KY, Choe YH, et al. Inhibition of VEGF blocks TGF-beta1 production through a PI3K/Akt signalling pathway. Eur Respir J. 2008;31:523–531
  25. Kwak YG, Song CH, Yi HK, Hwang PH, Kim JS, Lee KS, et al. Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. J Clin Invest. 2003;111:1083–1092
  26. Chauhan D, Catley L, Hideshima T, Li G, Leblanc R, Gupta D, et al. 2-Methoxyestradiol overcomes drug resistance in multiple myeloma cells. Blood. 2002;100:2187–2194
  27. Zilberberg L, Shinkaruk S, Lequin O, Rousseau B, Hagedorn M, Costa F, et al. Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitor. J Biol Chem. 2003;278:35564–35573
  28. Ferrara N, Rinaldi B, Corbi G, Conti V, Stiuso P, Boccuti S, et al. Exercise training promotes SIRT1 activity in aged rats. Rejuvenation Res. 2008;11:139–150
  29. Tournoy KG, Kips JC, Schou C, Pauwels RA. Airway eosinophilia is not a requirement for allergen-induced airway hyperresponsiveness. Clin Exp Allergy. 2000;30:79–85
  30. Cho JY, Miller M, Baek KJ, Han JW, Nayar J, Lee SY, et al. Inhibition of airway remodeling in IL-5-deficient mice. J Clin Invest. 2004;113:551–560
  31. Takeda K, Hamelmann E, Joetham A, Shultz LD, Larsen GL, Irvin CG, et al. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J Exp Med. 1997;186:449–454
  32. Kay AB. Asthma and inflammation. J Allergy Clin Immunol. 1991;87:893–910
  33. Holgate ST, Lackie P, Wilson S, Roche W, Davies D. Bronchial epithelium as a key regulator of airway allergen sensitization and remodeling in asthma. Am J Respir Crit Care Med. 2000;162(suppl):S113–S117
  34. D'Ambrosio D, Mariani M, Panina-Bordignon P, Sinigaglia F. Chemokines and their receptors guiding T lymphocyte recruitment in lung inflammation. Am J Respir Crit Care Med. 2001;164:1266–1275
  35. Barnes PJ, Chung KF, Page CP. Inflammatory mediators of asthma: an update. Pharmacol Rev. 1998;50:515–596
  36. Allegra P, Sterner R, Clayton DF, Allfrey VG. Affinity chromatographic purification of nucleosomes containing transcriptionally active DNA sequences. J Mol Biol. 1987;196:379–388
  37. Hebbes TR, Thorne AW, Crane-Robinson C. A direct link between core histone acetylation and transcriptionally active chromatin. EMBO J. 1988;7:1395–1402
  38. Tazi J, Bird A. Alternative chromatin structure at CpG islands. Cell. 1990;60:909–920
  39. Roth SY, Allis CD. Histone acetylation and chromatin assembly: a single escort, multiple dances?. Cell. 1996;87:5–8
  40. Pazin MJ, Kadonaga JT. What's up and down with histone deacetylation and transcription?. Cell. 1997;89:325–328
  41. Wade PA, Pruss D, Wolffe AP. Histone acetylation: chromatin in action. Trends Biochem Sci. 1997;22:128–132
  42. Kaeberlein M, McVey M, Guarente L. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev. 1999;13:2570–2580
  43. Tissenbaum HA, Guarente L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature. 2001;410:227–230
  44. Dryden SC, Nahhas FA, Nowak JE, Goustin AS, Tainsky MA. Role for human SIRT2 NAD-dependent deactivity in control of mitotic exit in the cell cycle. Mol Cell Biol. 2003;23:3173–3185
  45. Starai VJ, Escalante-Semerena JC. Identification of the protein acetyltransferase (Pat) enzyme that acetylates acetyl-CoA synthetase in Salmonella enterica. J Mol Biol. 2004;340:1005–1012
  46. Wang GL, Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem. 1995;270:1230–1237
  47. Brahimi-Horn C, Mazure N, Pouyssegur J. Signalling via the hypoxia-inducible factor-1alpha requires multiple posttranslational modifications. Cell Signal. 2005;17:1–9
  48. Jeong JW, Bae MK, Ahn MY, Kim SH, Sohn TK, Bae MH, et al. Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation. Cell. 2002;111:709–720
  49. Gradin K, Toftgard R, Poellinger L, Berghard A. Repression of dioxin signal transduction in fibroblasts. Identification of a putative repressor associated with Arnt. J Biol Chem. 1999;274:13511–13518
  50. Semenza GL. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol. 1999;15:551–578
  51. Kirsch CM, Brokaw JJ, Prow DM, White GW. Mechanism of platelet activating factor-induced vascular leakage in the rat trachea. Exp Lung Res. 1992;18:447–459
  52. Tamaoki J, Yamawaki I, Tagaya E, Kondo M, Aoshiba K, Nakata J, et al. Effect of azelastine on platelet-activating factor-induced microvascular leakage in rat airways. Am J Physiol Lung Cell Mol Physiol. 1999;276:L351–L357
  53. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 1995;146:1029–1039
  54. Lee CG, Link H, Baluk P, Homer RJ, Chapoval S, Bhandari V, et al. Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med. 2004;10:1095–1103
  55. Duan W, Aguinaldo Datiles AM, Leung BP, Vlahos CJ, Wong WS. An anti-inflammatory role for a phosphoinositide 3-kinase inhibitor LY294002 in a mouse asthma model. Int Immunopharmacol. 2005;5:495–502
  56. Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, Georgescu MM, et al. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res. 2000;60:1541–1545
  57. Semenza GL. Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol. 2002;64:993–998
  58. Treins C, Giorgetti-Peraldi S, Murdaca J, Semenza GL, Van Obberghen E. Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway. J Biol Chem. 2002;277:27975–27981
  59. Kwon HS, Ott M. The ups and downs of SIRT1. Trends Biochem Sci. 2008;33:517–525
  60. Tanno M, Sakamoto J, Miura T, Shimamoto K, Horio Y. Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1. J Biol Chem. 2007;282:6823–6832
  61. Nedachi T, Kadotani A, Ariga M, Katagiri H, Kanzaki M. Ambient glucose levels qualify the potency of insulin myogenic actions by regulating SIRT1 and FoxO3a in C2C12 myocytes. Am J Physiol Endocrinol Metab. 2008;294:E668–E678

 Supported by a grant from the Korea Healthcare technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A084144); by the Korea Science and Engineering Foundation (KOSEF) through the National Research Laboratory Program funded by the Ministry of Education, Science and Technology (R0A-2005-000-10052-0[2008]); and by a Korea Research Foundation Grant funded by the Korean Government (KRF-2008-313-E00249).

 Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.

PII: S0091-6749(09)01246-9

doi: 10.1016/j.jaci.2009.08.009

The Journal of Allergy and Clinical Immunology
Volume 125, Issue 2 , Pages 449-460.e14 , February 2010

Article Tools

* Image Usage & Resolution